HYDROFLUMETHIAZIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for hydroflumethiazide and what is the scope of patent protection?

Hydroflumethiazide is the generic ingredient in seven branded drugs marketed by Wyeth Ayerst, Par Pharm, Watson Labs, Shire Llc, Usl Pharma, Ivax Pharms, and Shire, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for hydroflumethiazide.

Sponsor	Phase
Pfizer

Sponsor

Phase

Pfizer

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shire	SALUTENSIN	hydroflumethiazide; reserpine	TABLET;ORAL	012359-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	HYDROFLUMETHIAZIDE	hydroflumethiazide	TABLET;ORAL	088528-001	Aug 15, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Pharms	RESERPINE AND HYDROFLUMETHIAZIDE	hydroflumethiazide; reserpine	TABLET;ORAL	088932-001	Jan 11, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Usl Pharma	HYDROFLUMETHIAZIDE AND RESERPINE	hydroflumethiazide; reserpine	TABLET;ORAL	088195-001	Oct 26, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	7
Applicants:	7
NDAs:	11
Drug Master File Entries:	2
Raw Ingredient (Bulk) Api Vendors:	82
Clinical Trials:	1
Patent Applications:	6,147
DailyMed Link:	HYDROFLUMETHIAZIDE at DailyMed